Regent’s Park Healthcare established its Cardiovascular Innovations Division in 2013 to develop collaborations with the Pharmaceuticals industry. Our existing client base includes some of the world’s leading pharma companies and cardiovascular research institutes. We have established a UK-wide network of over 40 clinical observation sites and seen over 6,500 patients at these observation sites in the last four years.
We are supported by our large infrastructure base and strong relationships with cardiologists, cardiac departments and cardiac healthcare professionals. We always seek long-term relationships with our sponsors to maximise the mutual benefit of our collaboration.
Our aim is to contribute to their strategic development as well as fulfilling their operational requirements.
Our main areas of interest are the following:
- Cardiac events & endpoint studies
- Coronary artery disease
- C-Reactive protein
- Heart Failure
We are actively seeking new relationships with clients from the Pharmaceutical, Biotech and Contract Research Organisation industry.
Please make contact with us using this email: email@example.com